Adicet Bio Inc [NASDAQ: ACET] gained 0.18% on the last trading session, reaching $0.6 price per share at the time.
Adicet Bio Inc represents 153.26 million in outstanding shares, while the company has a total market value of $92.11 million with the latest information. ACET stock price has been found in the range of $0.5792 to $0.6299.
If compared to the average trading volume of 1.66M shares, ACET reached a trading volume of 4692871 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Adicet Bio Inc [ACET]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ACET shares is $5.94 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ACET stock is a recommendation set at 1.25. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Guggenheim have made an estimate for Adicet Bio Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on September 30, 2024. The new note on the price target was released on September 11, 2024, representing the official price target for Adicet Bio Inc stock.
The Price to Book ratio for the last quarter was 0.46, with the Price to Cash per share for the same quarter was set at 0.67.
Trading performance analysis for ACET stock
Adicet Bio Inc [ACET] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 4.12. With this latest performance, ACET shares dropped by -29.76% in over the last four-week period, additionally sinking by -16.53% over the last 6 months – not to mention a drop of -37.53% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ACET stock in for the last two-week period is set at 35.59, with the RSI for the last a single of trading hit 0.0602, and the three-weeks RSI is set at 0.0665 for Adicet Bio Inc [ACET]. The present Moving Average for the last 50 days of trading for this stock 0.7930, while it was recorded at 0.5986 for the last single week of trading, and 0.7427 for the last 200 days.
Adicet Bio Inc (ACET) Capital Structure & Debt Analysis
According to recent financial data for Adicet Bio Inc. ( ACET), the Return on Equity (ROE) stands at -71.73%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -59.52%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Adicet Bio Inc’s Return on Invested Capital (ROIC) is -94.73%, showcasing its effectiveness in deploying capital for earnings.
Adicet Bio Inc (ACET) Efficiency & Liquidity Metrics
Based on Adicet Bio Inc’s (ACET) latest financial statements, the Debt-to-Equity Ratio is 0.14%, indicating its reliance on debt financing relative to shareholder equity.
Adicet Bio Inc (ACET) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Adicet Bio Inc. (ACET) effectively leverages its workforce, generating an average of -$756644.74 per employee. The company’s liquidity position is robust, with a Current Ratio of 5.62% and a Quick Ratio of 5.62%, indicating strong ability to cover short-term liabilities.
Adicet Bio Inc [ACET]: An earnings per share (EPS) analysis
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ACET. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Adicet Bio Inc go to 22.55%.
An analysis of Institutional ownership at Adicet Bio Inc [ACET]
There are presently around $36.35%, or 36.89%% of ACET stock, in the hands of institutional investors. The top three institutional holders of ACET stocks are: ORBIMED ADVISORS LLC with ownership of 11.45 million shares, which is approximately 12.6303%. TANG CAPITAL MANAGEMENT LLC, holding 8.22 million shares of the stock with an approximate value of $$9.94 million in ACET stocks shares; and TANG CAPITAL MANAGEMENT LLC, currently with $$9.12 million in ACET stock with ownership which is approximately 8.3205%.
